Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Terns Pharmaceuticals, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19Dec-31-18
Revenues0.039.61.032.30.061.7 
            Revenue growth-100.0%22.6%  -100.0%  
Cost of goods sold0.062.00.050.90.070.2 
Gross profit0.0-22.41.0-18.50.0-8.5 
            Gross margin -56.6%100.0%-57.4% -13.8% 
Research and development39.6 31.3 28.0  
General and administrative22.422.419.519.59.08.7 
EBIT-62.0-62.0-49.9-49.9-37.0-70.2 
            EBIT margin -156.6%-4986.0%-154.3% -113.8% 
Pre-tax income-60.0-60.0-49.7-49.7-39.8-68.8 
Income taxes0.40.40.50.50.80.0 
            Tax rate     0.0% 
Net income-60.3-60.3-50.2-50.2-29.4-0.1 
            Net margin -152.3%-5015.8%-155.2% -0.1% 
 
Diluted EPS($1.67)($1.67)($2.21)($2.21)($102.93)($374.39) 
Shares outstanding (diluted)36.036.022.722.70.30.0 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy